"Dr. Ankur Doshi began practicing internal medicine in fall of 1999, when he joined a primary care practice in the Memorial City area. He formed PrimeCare Medical Group in 2004 and started as a solo physician, seeking to pursue his vision of a medical practice. Dr. Doshi has strived to create a clinic that practices quality, evidence-based medicine incorporated with preventative medicine and wellness, which necessitates state-of-the art facilities, along with knowledgeable, compassionate, and dedicated providers and staff."

During the past decade, PrimeCare Medical Group conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 6 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "PrimeCare Medical Group" #1 sponsor was "Pfizer" with 5 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Meda Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "PrimeCare Medical Group" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "PrimeCare Medical Group" are "Cardiovascular Disease" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Diabetic Kidney Disease" (1 trials), "Heartburn" (1 trials) and "Kidney Disease, Chronic" (1 trials). Many other conditions were trialed in "PrimeCare Medical Group" in a lesser frequency.

Most popular intervention types in "PrimeCare Medical Group" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "bococizumab (PF-04950615)" (2 trials), "0 mg Induction ONLY" (1 trials), "150 mg Induction/Chronic" (1 trials) and "450 mg Induction/Chronic" (1 trials). Other intervention names were less common.

The vast majority of trials in "PrimeCare Medical Group" are 10 trials for "All" genders.

Currently, there are NaN active trials in "PrimeCare Medical Group". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in PrimeCare Medical Group, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in PrimeCare Medical Group, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".